• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西人群中丁酰胆碱酯酶 K 和-116A 变体与阿尔茨海默病的关联分析。

Association analysis between K and -116A variants of butyrylcholinesterase and Alzheimer's disease in a Brazilian population.

机构信息

Department of Genetics, Federal University of Paraná, Curitiba, Brazil.

出版信息

Chem Biol Interact. 2013 Mar 25;203(1):358-60. doi: 10.1016/j.cbi.2012.09.008. Epub 2012 Sep 27.

DOI:10.1016/j.cbi.2012.09.008
PMID:23022600
Abstract

In Alzheimer's disease (AD) a reduction in acetylcholinesterase (AChE) and an increase in butyrylcholinesterase (BChE) activity are observed. K variant (539T) is the most common variant of the BCHE gene and, although controversial, several studies reported association between K variant and AD. Previous results showed that the K variant alone is not capable of diminishing BChE activity, depending on the presence of the -116A variant. Considering that, we conducted a case-control association study using a clinically well defined group of AD patients (n = 82) and age and sex matched control subjects (EC; n = 78) in order to test the association with these variations of BCHE gene in a Brazilian population. The allele, genotype and haplotype frequencies of the K and the -116A variants of BCHE gene were not significantly different between cases and controls. Although not reaching statistical significance, the results suggested that the presence of -116A variant may have a protective effect against AD. The association of the K variant with AD in a controversial manner in different surveys is probably caused by its linkage disequilibrium with -116A that, by reducing BChE activity, potentially increases cholinergic transmission in comparison with usual genotypes.

摘要

在阿尔茨海默病(AD)中,观察到乙酰胆碱酯酶(AChE)减少和丁酰胆碱酯酶(BChE)活性增加。K 变体(539T)是 BCHE 基因最常见的变体,尽管存在争议,但几项研究报告了 K 变体与 AD 之间的关联。先前的结果表明,K 变体本身不能降低 BChE 活性,这取决于-116A 变体的存在。考虑到这一点,我们进行了一项病例对照关联研究,使用了一组临床定义明确的 AD 患者(n=82)和年龄和性别匹配的对照组(EC;n=78),以测试这些 BCHE 基因变体在巴西人群中的关联。BCHE 基因的 K 和-116A 变体的等位基因、基因型和单倍型频率在病例和对照组之间没有显著差异。尽管没有达到统计学意义,但结果表明-116A 变体的存在可能对 AD 具有保护作用。K 变体与 AD 的关联在不同的调查中存在争议,这可能是由于其与-116A 的连锁不平衡,通过降低 BChE 活性,与常见基因型相比,潜在地增加了胆碱能传递。

相似文献

1
Association analysis between K and -116A variants of butyrylcholinesterase and Alzheimer's disease in a Brazilian population.巴西人群中丁酰胆碱酯酶 K 和-116A 变体与阿尔茨海默病的关联分析。
Chem Biol Interact. 2013 Mar 25;203(1):358-60. doi: 10.1016/j.cbi.2012.09.008. Epub 2012 Sep 27.
2
-116A and K BCHE gene variants associated with obesity and hypertriglyceridemia in adolescents from Southern Brazil.-116A 和 K 位置的 BCHE 基因变异与巴西南部青少年肥胖和高三酰甘油血症有关。
Chem Biol Interact. 2013 Mar 25;203(1):341-3. doi: 10.1016/j.cbi.2012.09.006. Epub 2012 Sep 20.
3
Association of variants of the -116 site of the butyrylcholinesterase BCHE gene to enzyme activity and body mass index.丁酰胆碱酯酶(BCHE)基因-116位点变异与酶活性及体重指数的关联。
Chem Biol Interact. 2008 Sep 25;175(1-3):115-8. doi: 10.1016/j.cbi.2008.04.019. Epub 2008 Apr 29.
4
Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease.阿尔茨海默病中丁酰胆碱酯酶K变异体与载脂蛋白E基因型之间的关联分析。
Neurosci Lett. 2004 Nov 23;371(2-3):142-6. doi: 10.1016/j.neulet.2004.08.057.
5
Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).来自加那利群岛(西班牙)人群中的丁酰胆碱酯酶、载脂蛋白E与阿尔茨海默病
Neurosci Lett. 2007 Oct 29;427(1):34-8. doi: 10.1016/j.neulet.2007.08.059. Epub 2007 Sep 4.
6
Interaction between CYP19 aromatase and butyrylcholinesterase genes increases Alzheimer's disease risk.细胞色素P450 19芳香化酶(CYP19)与丁酰胆碱酯酶基因之间的相互作用会增加患阿尔茨海默病的风险。
Dement Geriatr Cogn Disord. 2005;20(2-3):153-7. doi: 10.1159/000087065. Epub 2005 Jul 13.
7
Neither the butyrylcholinesterase K variant nor transferrin C2 variant confers a risk for Alzheimer's disease in Koreans.
J Neural Transm (Vienna). 2001;108(10):1159-66. doi: 10.1007/s007020170005.
8
No association between butyrylcholinesterase K-variant and Alzheimer disease in Chinese.在中国,丁酰胆碱酯酶K-变体与阿尔茨海默病之间无关联。
Am J Med Genet. 2000 Apr 3;96(2):167-9.
9
Butyrylcholinesterase: K variant, plasma activity, molecular forms and rivastigmine treatment in Alzheimer's disease in a Southern Brazilian population.丁酰胆碱酯酶:巴西南部人群阿尔茨海默病中的K变异体、血浆活性、分子形式及卡巴拉汀治疗
Neurochem Int. 2015 Feb;81:57-62. doi: 10.1016/j.neuint.2014.12.009. Epub 2015 Jan 23.
10
Plasma butyrylcholinesterase activity: a possible biomarker for differential diagnosis between Alzheimer's disease and dementia with Lewy bodies?血浆丁酰胆碱酯酶活性:阿尔茨海默病与路易体痴呆鉴别诊断的潜在生物标志物?
Int J Neurosci. 2017 Dec;127(12):1082-1086. doi: 10.1080/00207454.2017.1329203. Epub 2017 May 23.

引用本文的文献

1
Confirmed Synergy Between the ɛ4 Allele of Apolipoprotein E and the Variant K of Butyrylcholinesterase as a Risk Factor for Alzheimer's Disease: A Systematic Review and Meta-Analysis.载脂蛋白E的ɛ4等位基因与丁酰胆碱酯酶变体K之间的协同作用被确认为阿尔茨海默病的一个风险因素:一项系统评价和荟萃分析。
J Alzheimers Dis Rep. 2023 Jun 19;7(1):613-625. doi: 10.3233/ADR-220084. eCollection 2023.
2
Association of and with Alzheimer's disease: Meta-analysis based on 56 genetic case-control studies of 12,563 cases and 12,622 controls.[基因名称1]和[基因名称2]与阿尔茨海默病的关联:基于对12563例病例和12622例对照的56项基因病例对照研究的荟萃分析。
Exp Ther Med. 2015 May;9(5):1831-1840. doi: 10.3892/etm.2015.2327. Epub 2015 Mar 3.
3
Butyrylcholinesterase K variant and Alzheimer's disease risk: a meta-analysis.
丁酰胆碱酯酶K变异体与阿尔茨海默病风险:一项荟萃分析。
Med Sci Monit. 2015 May 16;21:1408-13. doi: 10.12659/MSM.892982.